Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endocervical Lidocaine Spray for Pain Control During Office Hysteroscopy
NCT03382743Phase 3Unknown
- Sponsor
- Kasr Al Ainy Hospital
- Start
- Dec 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of lidocaine 10% oropharyngeal spray in procedural pain (2 arms), sponsored by Kasr Al Ainy Hospital. Primary endpoints: Pain sensation (Visual Analog Scale) and Procedure time. Status: unknown.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT03382743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03382743.